- Philips delivers patient monitoring, cardiac ultrasound and
image guided therapy solutions to Canada's largest heart health centre.
- Solutions-based approach to support the hospital in working
to better understand, treat and prevent heart disease.
AMSTERDAM, March 23, 2018 /CNW/ - Royal Philips (NYSE: PHG, AEX: PHIA), a global
leader in health technology has delivered a broad range of health
technology solutions to the University of
Ottawa Heart Institute (UOHI) - Canada's largest and foremost heart health
centre dedicated to understanding, treating, and preventing heart
disease. Today, the hospital celebrated the grand opening of
their expanded state-of-the-art cardiovascular care facility that
will meet the demands of delivering outstanding cardiovascular care
to a growing and changing patient population.
This new expansion will contain all life support services,
including operating rooms, interventional suites and a Cardiac
Surgery intensive care unit, providing greater capacity and
efficiencies and will support the advanced and rapidly changing
technologies required to care for patients with the most complex
medical needs.
In collaboration with hospitals and health systems, Philips aims
to leverage advanced technology, coupled with deep clinical and
consumer insights, to deliver solutions that improve people's
health and enable better outcomes across the health
continuum. The company's work with the hospital is a perfect
example of its solutions-based approach, providing innovative
technology into many areas of the Heart Institute's 145,000
square-foot tower.
Image-guided therapy solutions
Seven of the ten labs
will feature Philips newest technology in Canada – Azurion combined with intravascular
ultrasound and clinical informatics – for performing a range of
cardiac interventions. Azurion is a next generation image-guided
therapy platform that features a state-of-the-art ergonomic design,
with an easy-to-use touch screen intuitive user interface enabling
clinicians to confidently perform a wide range of routine and
complex procedures in the cardiac interventional labs and to
provide superior care to patients.
Azurion also features an enhanced flat-panel detector, and
Philips' newly developed ConnectOS for the seamless integration of
real-time information from all relevant technologies in the
interventional lab. All of these components work together to
deliver high image quality at ultra-low X-ray dose and real-time
image processing on multiple work spots within the cardiac
interventional suite. Parallel working enables the team of
clinicians to complete different tasks simultaneously in the
interventional lab, saving valuable time without compromising
quality of care.
Patient monitoring solutions
In addition to these
image-guided therapy solutions, Philips has provided the UOHI's new
Cardiac Surgery intensive care unit with a new patient monitoring
network consisting of 22 Philips IntelliVue MX800 and central
surveillance stations. This gives healthcare providers a holistic
view of their patients' status, allowing them to make more informed
decisions at the point of care.
"The University of Ottawa Heart
Institute is thrilled that the time has finally come to introduce
our next generation, state-of-the art expanded facility that will
enable us to continue providing world-class cardiac care for
patients and families of the Greater Ottawa Region and beyond,"
said Dr. Thierry Mesana, President
and CEO, The University of Ottawa Heart
Institute. "We strive to deliver high-tech care with a
personal touch, shape the way cardiovascular medicine is practiced,
and revolutionize cardiac treatment and understanding – and we
could not do this without having access to the newest and most
innovative health system technological solutions
available."
"At Philips we look beyond technology and into the experiences
of patients, providers, caregivers across the entire health
continuum," said Iain Burns,
President & CEO, Philips Canada. "Our work with The
University of Ottawa Heart Institute is
a fantastic example of how we aim to understand the needs of our
customers, so that we can offer a flexible business partnership
that promotes a smooth working relationship, so that the hospital
can focus on what matters: advancing the health of patients in
their community."
As a leading innovator in cardiovascular care, Philips has
focused on delivering integrated solutions comprising of
interventional imaging systems, smart devices, software and
services – that the company put together with its partners, like
the UOHI, to solve a particular problem. In this way, Philips
actively addresses the opportunities for healthcare providers to
help improve patient outcomes and productivity.
About Royal
Philips
Royal
Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and
enabling better outcomes across the health continuum from healthy
living and prevention, to diagnosis, treatment and home care.
Philips leverages advanced technology and deep clinical and
consumer insights to deliver integrated solutions. Headquartered in
the Netherlands, the company is a
leader in diagnostic imaging, image-guided therapy, patient
monitoring and health informatics, as well as in consumer health
and home care. Philips' health technology portfolio generated 2017
sales of EUR 17.8 billion and employs
approximately 74,000 employees with sales and services in more than
100 countries. News about Philips can be found at:
www.philips.com/newscenter
SOURCE Royal Philips